Imaeda et al.
demonstrated that the mortality associated with acetaminophen-induced hepatotoxicity was partially dependent on NLRP3 38. Mice deficient in components of the NLRP3 inflammasome were protected from the lethal effects of RO4929097 cell line acetaminophen-induced hepatotoxicity in vivo and had reduced liver injury compared to WT mice. Although not directly examined in this study, it is likely that acetaminophen-induced necrosis of hepatocytes, similar to necrosis induced by pressure-disruption and complement, activates the NLRP3 inflammasome in macrophages that encounter these necrotic cells with resultant activation of caspase-1 and processing and secretion of IL-1β. Interestingly, DNA released from damaged hepatocytes was found to stimulate the production of pro-IL-1β and pro-IL-18 through LEE011 manufacturer stimulation of TLR9 38. This raises the possibility that cytosolic nucleic acid sensors such as RIG-I and AIM2 may also play a role in sterile inflammatory responses to necrotic cell death. In addition, NLRP3 has also been shown to be activated in response to cytoplasmic DNA 39, which may also play a role in NLRP3 inflammasome activation in response to acetaminophen-induced hepatotoxicity. Tumor cell death induced
by certain chemotherapeutic agents such as anthracyclines and oxaliplatin elicit an immunogenic response that is required for tumor eradication. Ghiringhelli et al. found that oxaliplatin-treated tumor cells were capable of activating the NLRP3 inflammasome in dendritic cells resulting in the secretion of IL-1β 37. Importantly, the priming of IFN-γ-producing CD8+ T cells by dying tumor cells was also dependent on the NLRP3 inflammasome. The importance of NLRP3 in mediating the adjuvant
effects of alum and uric acid has parallels to these new findings that necrotic cells mediate their immunogenicity through NLRP3. Ghiringhelli et al. also found that tumors established Ergoloid in mice deficient in components of the NLRP3-inflammasome had poorer responses to oxaliplatin compared with WT mice 37. Both Iyer et al. and Ghiringhelli et al. demonstrated that ATP released from the necrotic cells was responsible for activation of the NLRP3 inflammasome via the P2X7 receptor 22, 37. Importantly, uric acid, another DAMP that has been postulated to play a role in responses to necrotic cells, was not involved in the ability for necrotic cells to activate the NLRP3 inflammasome. The half-life of extracellular ATP is brief due to efficient degradation by ectoenzymes. Hence, preformed ATP released from the dying cell is likely sensed in close proximity to the necrotic insult. Additionally, we found actively respiring mitochondria released from necrotic cells generate ATP that activates the NLRP3 inflammasome, and also allows the ATP to be carried further from the site of initial insult 22 (Fig. 2).